Finance News – Gsk
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Tariffs
Stock
Investors
Ceo
Stock Market
Crypto Assets
Ethereum
Cryptocurrency
Price
Markets
Xrp
Eth
Etf
Bse
Earnings
Ipo
Stablecoin
Investment
Blockchain
Revenue
Solana
Index
Trade
Inflation
Sec
Interest Rates
Wall Street
Token
Sensex
Coinbase
Treasury
Federal Reserve
Nasdaq
Profit
Traders
Nse
China
Nifty
Bse Sensex
Sp 500
Investor
Gold
Tesla
Company
Economy
Kotak
Timeframe
Fusion Finance
Ftm
Federal Jurisdiction
Real Estate Board
Surface Discovery
Persons Discharging Managerial Responsibilities
Web Browser
Electric Pickups
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Business Insider Markets • Jul 17, 2025
GSKâs Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus Associate...
The introduction of GSK’s new therapy for itching related to primary biliary cholangitis could potentially generate significant revenue by meeting patient needs not fully addressed...
Read Full Article →
City A.M. • May 12, 2025
GSK and Astrazeneca shares slump as Trump vows drug price cut
The announcement of new executive measures aimed at lowering medication costs has led to a decline in the stock values of major pharmaceutical companies, reflecting investor concer...
Read Full Article →
City A.M. • May 07, 2025
FTSE 100’s record run fades as pharma stocks slide on new Trump appointment
The decline in major pharmaceutical shares contributed to a modest drop in the FTSE 100, signaling potential market uncertainty linked to changes in US regulatory leadership.
Read Full Article →